公司资料
Helius Medical Technologies 股价、新闻与催化剂
- 股票代码:
- HSDT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.10 USD (+12.90%)
收盘价
最后更新: 2026年8月21日
93.4M USD
市值
股价为何变动
As of Aug 21, 2026, HSDT closed up 12.9% at $2.10. No new same-company headline was identified in the current news window.
公司概览
业务概览
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms. Its business is rooted in device-based neuroscience rather than pharmaceuticals.
所在地与行业分类
Helius is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
商业模式特征
The company depends on product adoption, clinical acceptance, and the ability to expand use of its neuromodulation platform. Investors usually watch commercialization progress and regulatory or reimbursement developments.
生物医药行业定位
Helius occupies a neuromodulation niche within healthcare technology. It is not biotech, but it sits close to the neuroscience device layer.
未来催化剂
- Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
近期新闻
- 01
- 02
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。